Unknown

Dataset Information

0

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.


ABSTRACT: BACKGROUND: Neoadjuvant chemoradiotherapy is the treatment of choice in advanced rectal cancer, even though there are many patients who will not benefit from it. There are still no effective methods for predicting which patients will respond or not. The present study aimed to define the genomic profile of rectal tumors and to identify alterations that are predictive of response in order to optimize therapeutic strategies. METHODS: Forty-eight candidates for neoadjuvant chemoradiotherapy were recruited and their pretherapy biopsies analyzed by array Comparative Genomic Hybridization (aCGH). Pathologic response was evaluated by tumor regression grade. RESULTS: Both Hidden Markov Model and Smoothing approaches identified similar alterations, with a prevalence of DNA gains. Non responsive patients had a different alteration profile from responsive ones, with a higher number of genome changes mainly located on 2q21, 3q29, 7p22-21, 7q21, 7q36, 8q23-24, 10p14-13, 13q12, 13q31-34, 16p13, 17p13-12 and 18q23 chromosomal regions. CONCLUSIONS: This exploratory study suggests that an in depth characterization of chromosomal alterations by aCGH would provide useful predictive information on response to neoadjuvant chemoradiotherapy and could help to optimize therapy in rectal cancer patients.The data discussed in this study are available on the NCBI Gene Expression Omnibus [GEO: GSE25885].

SUBMITTER: Molinari C 

PROVIDER: S-EPMC3236016 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.

Molinari Chiara C   Ballardini Michela M   Teodorani Nazario N   Giannini Massimo M   Zoli Wainer W   Emiliani Ermanno E   Lucci Enrico E   Passardi Alessandro A   Rosetti Paola P   Saragoni Luca L   Guidoboni Massimo M   Amadori Dino D   Calistri Daniele D  

Radiation oncology (London, England) 20111118


<h4>Background</h4>Neoadjuvant chemoradiotherapy is the treatment of choice in advanced rectal cancer, even though there are many patients who will not benefit from it. There are still no effective methods for predicting which patients will respond or not. The present study aimed to define the genomic profile of rectal tumors and to identify alterations that are predictive of response in order to optimize therapeutic strategies.<h4>Methods</h4>Forty-eight candidates for neoadjuvant chemoradiothe  ...[more]

Similar Datasets

2011-11-17 | E-GEOD-25885 | biostudies-arrayexpress
2011-11-17 | GSE25885 | GEO
| S-EPMC7408989 | biostudies-literature
| S-EPMC5037760 | biostudies-literature
| S-EPMC8484095 | biostudies-literature
| S-EPMC5233494 | biostudies-literature
| S-EPMC8290248 | biostudies-literature
2019-07-01 | GSE123390 | GEO
| S-EPMC6224241 | biostudies-other
| S-EPMC7400706 | biostudies-literature